s6y

ARGENX SE

Ticker
ARGX
CIK
1697862
Industry
Biological Products, (No Diagnostic Substances)
Formerly
argenx N.V

Ownership 29

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G/A Major Shareholders
  8. SC 13G/A Major Shareholders
  9. SC 13G/A Major Shareholders
  10. SC 13G/A Major Shareholders

All 29 ownership filings

Prospectus 30

  1. SC TO-T/A Third party tender offer statement
  2. SC TO-T/A Third party tender offer statement
  3. SC TO-T/A Third party tender offer statement
  4. SC TO-T Third party tender offer statement
  5. SC TO-C Written communication relating to an issuer or third party tender offer
  6. SC TO-C Written communication relating to an issuer or third party tender offer
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. 424B5 Prospectus filed pursuant to Rule 424(b)(5)

All 30 prospectus filings

Other 239

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  3. SCHEDULE 13G/A
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. SCHEDULE 13G/A

All 239 other filings